MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$568,791
(11.72%↑ Y/Y)
Total operating
expenses
$567,833
(-11.74%↓ Y/Y)
Interest expense, net
$958
(-0.21%↓ Y/Y)
Stock-based compensation
$277,226
(-6.42%↓ Y/Y)
General and
administrative
$270,153
(10.67%↑ Y/Y)
Research and development
$20,454
(-80.14%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
RetinalGenix Technologies Inc. (RTGN)
RetinalGenix Technologies Inc. (RTGN)